Literature DB >> 20087861

Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort.

Tanja Stocks1, Maria-Pia Hergens, Anders Englund, Weimin Ye, Pär Stattin.   

Abstract

Data from prospective studies on blood pressure and prostate cancer risk are limited, and results are inconclusive. Baseline measurements of height, weight and blood pressure were available in 336,159 men in the Swedish Construction Workers cohort. During an average of 22.2 years of follow-up, 10,002 incident cases and 2,601 fatal cases of prostate cancer were identified in National registers. For 5,219 cases, tumor characteristics were available; 2,817 tumors were classified as nonaggressive and 2,402 as aggressive. Relative risks of disease were estimated from Cox regression models, using attained age as time-scale, and adjusting for birth year, smoking status and body mass index (BMI). Top compared to bottom quintile level of systolic or diastolic blood pressure was associated with a significant 15-20% decreased risk of incident prostate cancer (p for trend: systolic < 0.0001, diastolic = 0.3), but blood pressure was not significantly associated with risk of fatal prostate cancer. BMI was not associated with prostate cancer incidence, but was positively associated with fatal prostate cancer; men in the top quintile had a 30% increased risk (p for trend = 0.0004). The associations between blood pressure and BMI and nonaggressive tumors were similar to those of incident prostate cancer, and associations with aggressive tumors were similar to those of fatal prostate cancer. Data from our study suggest that hypertension is associated with a decreased risk of incident prostate cancer, but the explanation for this finding is unclear. Our study support a positive association between overweight and risk of fatal prostate cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20087861     DOI: 10.1002/ijc.25171

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

Review 1.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

2.  Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study.

Authors:  Adriana C Vidal; Lauren E Howard; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-27       Impact factor: 4.254

Review 3.  A stage-dependent link between metabolic syndrome components and incident prostate cancer.

Authors:  Jan Hammarsten; Jan-Erik Damber; Mohammad A Haghsheno; Dan Mellström; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

4.  Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.

Authors:  Elisabeth Möller; Kathryn M Wilson; Julie L Batista; Lorelei A Mucci; Katarina Bälter; Edward Giovannucci
Journal:  Int J Cancer       Date:  2015-09-23       Impact factor: 7.396

5.  Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Sofia Christakoudi; Artemisia Kakourou; Georgios Markozannes; Ioanna Tzoulaki; Elisabete Weiderpass; Paul Brennan; Marc Gunter; Christina C Dahm; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Anne-Laure Madika; Gianluca Severi; Verena Katzke; Tilman Kühn; Manuela M Bergmann; Heiner Boeing; Anna Karakatsani; Georgia Martimianaki; Paschalis Thriskos; Giovanna Masala; Sabina Sieri; Salvatore Panico; Rosario Tumino; Fulvio Ricceri; Antonio Agudo; Daniel Redondo-Sánchez; Sandra M Colorado-Yohar; Olatz Mokoroa; Olle Melander; Tanja Stocks; Christel Häggström; Sophia Harlid; Bas Bueno-de-Mesquita; Carla H van Gils; Roel C H Vermeulen; Kay-Tee Khaw; Nicholas J Wareham; Tammy Y N Tong; Heinz Freisling; Mattias Johansson; Hannah Lennon; Dagfinn Aune; Elio Riboli; Dimitrios Trichopoulos; Antonia Trichopoulou; Konstantinos K Tsilidis
Journal:  Int J Cancer       Date:  2019-08-20       Impact factor: 7.396

6.  Midlife metabolic factors and prostate cancer risk in later life.

Authors:  Barbra A Dickerman; Johanna E Torfadottir; Unnur A Valdimarsdottir; Kathryn M Wilson; Laufey Steingrimsdottir; Thor Aspelund; Julie L Batista; Katja Fall; Edward Giovannucci; Lara G Sigurdardottir; Laufey Tryggvadottir; Vilmundur Gudnason; Sarah C Markt; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2017-11-16       Impact factor: 7.396

7.  Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.

Authors:  Monika Izano; Esther K Wei; Caroline Tai; Helen Swede; Steven Gregorich; Tamara B Harris; Heidi Klepin; Suzanne Satterfield; Rachel Murphy; Anne B Newman; Susan M Rubin; Dejana Braithwaite
Journal:  Int J Cancer       Date:  2015-10-19       Impact factor: 7.396

8.  Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study.

Authors:  A Discacciati; N Orsini; S-O Andersson; O Andrén; J-E Johansson; A Wolk
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

9.  Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies.

Authors:  Xiaoyi Zhang; Guiqin Zhou; Bo Sun; Guohua Zhao; Dezhong Liu; Jiage Sun; Chuanhai Liu; Hui Guo
Journal:  Oncol Lett       Date:  2014-12-31       Impact factor: 2.967

10.  Asthma and Risk of Prostate Cancer: A Population-Based Case-Cohort Study in Taiwan.

Authors:  Yu-Li Su; Ching-Lan Chou; Kun-Ming Rau; Charles Tzu-Chi Lee
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.